Que Chi Truong-Bolduc, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Staphylococcus aureus | 26 | 2024 | 1451 | 5.880 |
Why?
|
Bacterial Proteins | 22 | 2024 | 3848 | 2.680 |
Why?
|
Membrane Transport Proteins | 10 | 2024 | 1028 | 2.550 |
Why?
|
Staphylococcal Infections | 9 | 2024 | 1400 | 2.410 |
Why?
|
Gene Expression Regulation, Bacterial | 14 | 2018 | 1122 | 1.630 |
Why?
|
Multidrug Resistance-Associated Proteins | 6 | 2024 | 107 | 1.170 |
Why?
|
Microbial Sensitivity Tests | 12 | 2024 | 1877 | 1.040 |
Why?
|
Ciprofloxacin | 5 | 2021 | 315 | 0.890 |
Why?
|
Anti-Bacterial Agents | 16 | 2024 | 7181 | 0.720 |
Why?
|
Toll-Like Receptor 2 | 2 | 2019 | 354 | 0.710 |
Why?
|
Congo Red | 1 | 2019 | 46 | 0.700 |
Why?
|
Tunicamycin | 1 | 2019 | 112 | 0.690 |
Why?
|
Pseudomonas Infections | 1 | 2024 | 613 | 0.680 |
Why?
|
Teichoic Acids | 1 | 2019 | 66 | 0.680 |
Why?
|
Genes, Regulator | 3 | 2011 | 378 | 0.670 |
Why?
|
Fosfomycin | 1 | 2018 | 25 | 0.650 |
Why?
|
Tetracycline | 4 | 2022 | 214 | 0.630 |
Why?
|
Transcription, Genetic | 6 | 2017 | 7722 | 0.540 |
Why?
|
Epithelial Cells | 3 | 2017 | 3690 | 0.530 |
Why?
|
Phagosomes | 1 | 2017 | 193 | 0.530 |
Why?
|
Escherichia coli Proteins | 1 | 2022 | 1050 | 0.520 |
Why?
|
Staphylococcal Skin Infections | 2 | 2014 | 75 | 0.470 |
Why?
|
Host-Pathogen Interactions | 2 | 2021 | 1477 | 0.410 |
Why?
|
Drug Resistance, Bacterial | 7 | 2018 | 1035 | 0.400 |
Why?
|
Aza Compounds | 1 | 2011 | 32 | 0.400 |
Why?
|
Oxidoreductases | 1 | 2012 | 424 | 0.350 |
Why?
|
Promoter Regions, Genetic | 8 | 2017 | 5867 | 0.320 |
Why?
|
Trans-Activators | 2 | 2017 | 2924 | 0.310 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2012 | 1213 | 0.290 |
Why?
|
beta-Lactams | 2 | 2024 | 160 | 0.280 |
Why?
|
Quinolines | 1 | 2011 | 732 | 0.270 |
Why?
|
Genes, Bacterial | 2 | 2007 | 1079 | 0.260 |
Why?
|
Protein Binding | 6 | 2019 | 9386 | 0.260 |
Why?
|
Repressor Proteins | 3 | 2014 | 3023 | 0.250 |
Why?
|
Microbial Viability | 2 | 2017 | 234 | 0.250 |
Why?
|
Fluoroquinolones | 4 | 2013 | 310 | 0.250 |
Why?
|
Oxacillin | 1 | 2024 | 42 | 0.240 |
Why?
|
Nafcillin | 1 | 2024 | 25 | 0.240 |
Why?
|
Pyocyanine | 1 | 2024 | 18 | 0.240 |
Why?
|
Protein Processing, Post-Translational | 2 | 2012 | 1990 | 0.240 |
Why?
|
Quinolones | 4 | 2007 | 367 | 0.210 |
Why?
|
Mupirocin | 1 | 2021 | 56 | 0.200 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 4751 | 0.200 |
Why?
|
Electrophoretic Mobility Shift Assay | 3 | 2014 | 300 | 0.190 |
Why?
|
Chlorhexidine | 1 | 2021 | 162 | 0.180 |
Why?
|
DNA-Binding Proteins | 1 | 2018 | 9648 | 0.180 |
Why?
|
Oxygen | 1 | 2012 | 4189 | 0.180 |
Why?
|
Norfloxacin | 2 | 2010 | 25 | 0.180 |
Why?
|
Molecular Sequence Data | 8 | 2014 | 18111 | 0.170 |
Why?
|
Potassium | 1 | 2022 | 1336 | 0.160 |
Why?
|
Chloramphenicol | 1 | 2017 | 75 | 0.150 |
Why?
|
Drug Resistance, Multiple, Bacterial | 3 | 2008 | 567 | 0.150 |
Why?
|
Ornithine | 1 | 2017 | 78 | 0.150 |
Why?
|
ATP-Binding Cassette Transporters | 2 | 2014 | 560 | 0.150 |
Why?
|
Erythromycin | 1 | 2017 | 120 | 0.150 |
Why?
|
Citrates | 1 | 2017 | 131 | 0.150 |
Why?
|
Sodium | 1 | 2022 | 1623 | 0.140 |
Why?
|
Pseudomonas aeruginosa | 1 | 2024 | 1219 | 0.140 |
Why?
|
Genetic Fitness | 1 | 2017 | 121 | 0.140 |
Why?
|
Abscess | 2 | 2017 | 607 | 0.140 |
Why?
|
Chloroquine | 1 | 2017 | 280 | 0.130 |
Why?
|
Biological Transport, Active | 2 | 2006 | 349 | 0.130 |
Why?
|
Structure-Activity Relationship | 1 | 2021 | 3129 | 0.130 |
Why?
|
Base Sequence | 5 | 2014 | 12797 | 0.130 |
Why?
|
Protein Kinases | 1 | 2022 | 1640 | 0.130 |
Why?
|
Gene Knockout Techniques | 1 | 2018 | 809 | 0.120 |
Why?
|
Polyamines | 1 | 2013 | 120 | 0.110 |
Why?
|
DNA, Bacterial | 1 | 2018 | 1465 | 0.110 |
Why?
|
Lipopolysaccharides | 1 | 2019 | 2216 | 0.100 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2014 | 2557 | 0.090 |
Why?
|
Escherichia coli | 1 | 2022 | 4217 | 0.090 |
Why?
|
Anti-Infective Agents | 2 | 2005 | 972 | 0.080 |
Why?
|
Gluconates | 1 | 2007 | 29 | 0.080 |
Why?
|
Genes, MDR | 1 | 2007 | 37 | 0.070 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2010 | 1723 | 0.070 |
Why?
|
Stress, Physiological | 1 | 2014 | 1403 | 0.070 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2021 | 5172 | 0.070 |
Why?
|
Topoisomerase II Inhibitors | 1 | 2005 | 87 | 0.070 |
Why?
|
Fatty Acids | 1 | 2013 | 1809 | 0.070 |
Why?
|
Tetracyclines | 1 | 2005 | 60 | 0.060 |
Why?
|
Amino Acid Sequence | 3 | 2007 | 13815 | 0.060 |
Why?
|
Transcription Factors | 2 | 2014 | 12208 | 0.060 |
Why?
|
Mice, Inbred BALB C | 1 | 2013 | 6386 | 0.060 |
Why?
|
RNA, Bacterial | 1 | 2006 | 390 | 0.060 |
Why?
|
RNA, Messenger | 3 | 2006 | 13033 | 0.060 |
Why?
|
Humans | 9 | 2024 | 744343 | 0.060 |
Why?
|
Pyrrolidines | 1 | 2005 | 342 | 0.060 |
Why?
|
Blotting, Western | 1 | 2011 | 5179 | 0.060 |
Why?
|
Cell Line | 1 | 2017 | 15997 | 0.050 |
Why?
|
Mutation | 6 | 2017 | 29786 | 0.050 |
Why?
|
Mass Spectrometry | 1 | 2008 | 2203 | 0.050 |
Why?
|
Mice | 4 | 2017 | 81183 | 0.050 |
Why?
|
Substrate Specificity | 1 | 2005 | 1801 | 0.050 |
Why?
|
Haemophilus Vaccines | 1 | 2000 | 69 | 0.050 |
Why?
|
Sequence Alignment | 1 | 2005 | 2256 | 0.050 |
Why?
|
Flow Cytometry | 1 | 2011 | 5974 | 0.050 |
Why?
|
Antigenic Variation | 1 | 2000 | 125 | 0.050 |
Why?
|
Gene Expression | 1 | 2013 | 7799 | 0.050 |
Why?
|
Cloning, Molecular | 1 | 2006 | 4320 | 0.050 |
Why?
|
Haemophilus influenzae | 1 | 2000 | 171 | 0.050 |
Why?
|
Skin | 1 | 2013 | 4364 | 0.040 |
Why?
|
5' Untranslated Regions | 1 | 2001 | 249 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2017 | 9274 | 0.040 |
Why?
|
Gene Expression Profiling | 2 | 2014 | 9438 | 0.040 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 16689 | 0.040 |
Why?
|
Phosphorylation | 1 | 2010 | 8436 | 0.040 |
Why?
|
Otitis Media | 1 | 2000 | 277 | 0.040 |
Why?
|
Phylogeny | 1 | 2005 | 2803 | 0.040 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2000 | 404 | 0.040 |
Why?
|
Iron | 2 | 2017 | 1774 | 0.040 |
Why?
|
Siderophores | 1 | 2017 | 57 | 0.040 |
Why?
|
Genetic Complementation Test | 1 | 2017 | 562 | 0.040 |
Why?
|
Animals | 5 | 2017 | 168757 | 0.030 |
Why?
|
Child | 1 | 2024 | 77709 | 0.030 |
Why?
|
Bambermycins | 1 | 2014 | 11 | 0.030 |
Why?
|
Binding Sites | 1 | 2003 | 6114 | 0.030 |
Why?
|
Korea | 1 | 2013 | 99 | 0.030 |
Why?
|
Cell Membrane | 1 | 2003 | 3748 | 0.030 |
Why?
|
Plasmids | 1 | 2017 | 2307 | 0.030 |
Why?
|
Naphthyridines | 1 | 2005 | 118 | 0.020 |
Why?
|
DNA Topoisomerases, Type II | 1 | 2005 | 121 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2014 | 3086 | 0.010 |
Why?
|
Transformation, Bacterial | 1 | 2000 | 78 | 0.010 |
Why?
|
Chinchilla | 1 | 2000 | 75 | 0.010 |
Why?
|
Hospitals | 1 | 2013 | 3952 | 0.010 |
Why?
|
Ear, Middle | 1 | 2000 | 334 | 0.010 |
Why?
|
Mutagenesis, Insertional | 1 | 2000 | 655 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2000 | 2839 | 0.010 |
Why?
|
Male | 1 | 2013 | 350118 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18029 | 0.010 |
Why?
|
Drug Design | 1 | 2000 | 1076 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2000 | 6622 | 0.010 |
Why?
|
Vaccination | 1 | 2000 | 3278 | 0.000 |
Why?
|